Life AI Net
الرئيسية
الأرشيف
الحاسبات
الدليل
النشرة البريدية
تسجيل الدخول
العربية
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
الرئيسية
الأرشيف
الحاسبات
الدليل
النشرة البريدية
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
تسجيل الدخول
الرئيسية
الأرشيف
الحاسبات
الدليل
More
مباشر
Clinical OMICs
CAR T-Cell Therapy Expands Access to Kidney Transplants
Endpoints News
Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D deal
FierceBiotech
Lilly, Boehringer to slash at least $1B each from planned investments in Germany
Clinical OMICs
Genetically Raised Pulse Pressure Predisposes to Dementia-Linked Death
Clinical OMICs
Engineered Islets Could Eliminate Need for Immunosuppression in Type 1 Diabetes
FierceBiotech
Unlocking Unstructured Data with AI for Optimized Protocol Development
Endpoints News
Bristol Myers turns focus to AI costs after broad rollout to workers
Clinical OMICs
New Tumor Survival Mechanism Revealed in Aggressive ALT Cancers
Clinical OMICs
Veracyte Launches Test Identifying Breast Cancer Patients Who Don’t Need Chemo
Endpoints News
Axsome pushes back generic entry for narcolepsy drug until 2040
Clinical OMICs
Nanotube Sensor Provides Chemical Imaging for Earlier Detection of Bladder Cancer Recurrence
Endpoints News
FDA guides pharma on explaining unapproved drugs to payors
Clinical OMICs
CAR T-Cell Therapy Expands Access to Kidney Transplants
Endpoints News
Alnylam to pay $30M upfront to AI startup Inceptive in RNA R&D deal
FierceBiotech
Lilly, Boehringer to slash at least $1B each from planned investments in Germany
Clinical OMICs
Genetically Raised Pulse Pressure Predisposes to Dementia-Linked Death
Clinical OMICs
Engineered Islets Could Eliminate Need for Immunosuppression in Type 1 Diabetes
FierceBiotech
Unlocking Unstructured Data with AI for Optimized Protocol Development
Endpoints News
Bristol Myers turns focus to AI costs after broad rollout to workers
Clinical OMICs
New Tumor Survival Mechanism Revealed in Aggressive ALT Cancers
Clinical OMICs
Veracyte Launches Test Identifying Breast Cancer Patients Who Don’t Need Chemo
Endpoints News
Axsome pushes back generic entry for narcolepsy drug until 2040
Clinical OMICs
Nanotube Sensor Provides Chemical Imaging for Earlier Detection of Bladder Cancer Recurrence
Endpoints News
FDA guides pharma on explaining unapproved drugs to payors
الأرشيف
هذا المقال غير متوفر في الأرشيف.